Shyam Prabhakaran to Fibrinolytic Agents
This is a "connection" page, showing publications Shyam Prabhakaran has written about Fibrinolytic Agents.
Connection Strength
6.522
-
Racial disparities in refusal of stroke thrombolysis in Chicago. Neurology. 2018 01 30; 90(5):e359-e364.
Score: 0.543
-
Pace of Progress in Stroke Thrombolysis: Are Hospitals Running To Stand Still? Circ Cardiovasc Qual Outcomes. 2017 01; 10(1).
Score: 0.507
-
Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times. Circ Cardiovasc Qual Outcomes. 2016 09; 9(5):585-92.
Score: 0.496
-
Intervention for Acute Stroke--Reply. JAMA. 2015 Aug 11; 314(6):626-7.
Score: 0.460
-
Acute stroke intervention: a systematic review. JAMA. 2015 Apr 14; 313(14):1451-62.
Score: 0.450
-
Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections. Cerebrovasc Dis. 2014; 38(4):247-53.
Score: 0.437
-
Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Sep; 23(8):2139-2144.
Score: 0.428
-
Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol. 2013 Sep 01; 70(9):1126-32.
Score: 0.402
-
Response to the letter by Lee et al. J Stroke Cerebrovasc Dis. 2013 Aug; 22(6):894.
Score: 0.374
-
Intravenous thrombolysis in a stroke patient taking dabigatran. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):916.e11-2.
Score: 0.367
-
Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke. 2012 Mar; 43(3):875-7.
Score: 0.356
-
Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke. 2011 Jun; 42(6):1626-30.
Score: 0.342
-
Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke. Neurology. 2022 04 19; 98(16):e1596-e1604.
Score: 0.181
-
Door-In-Door-Out Process Times at Primary Stroke Centers in Chicago. Ann Emerg Med. 2021 11; 78(5):674-681.
Score: 0.176
-
Presentation, Evaluation, Management, and Outcomes of Acute Stroke in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2018; 51(1-2):104-112.
Score: 0.141
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
Score: 0.118
-
Telestroke in an urban setting. Telemed J E Health. 2014 Sep; 20(9):855-7.
Score: 0.106
-
Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke. Cerebrovasc Dis. 2014; 37(5):356-63.
Score: 0.106
-
Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke. 2013 Sep; 44(9):2509-12.
Score: 0.100
-
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012 Sep; 43(9):2293-9.
Score: 0.093
-
Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis. Neurology. 2011 Dec 13; 77(24):2082-8.
Score: 0.089
-
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2010 May; 67(5):559-63.
Score: 0.079
-
Vive la difference! On potential sex differences in response to thrombolysis. Neurology. 2008 Sep 30; 71(14):1048-9.
Score: 0.071
-
Experimental treatments for acute ischaemic stroke. Lancet. 2007 Jan 27; 369(9558):331-41.
Score: 0.064
-
Intracranial Atherosclerotic Disease. Stroke. 2019 05; 50(5):1286-1293.
Score: 0.037